SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 47 filers reported holding SUNESIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $7,248,000 | +669.4% | 5,965,455 | +163.3% | 0.25% | +492.9% |
| Q4 2018 | $942,000 | -79.2% | 2,265,455 | 0.0% | 0.04% | -74.7% |
| Q3 2018 | $4,531,000 | -5.7% | 2,265,455 | 0.0% | 0.17% | -16.6% |
| Q2 2018 | $4,803,000 | -22.1% | 2,265,455 | 0.0% | 0.20% | -30.9% |
| Q1 2018 | $6,162,000 | -26.3% | 2,265,455 | 0.0% | 0.29% | -33.9% |
| Q4 2017 | $8,360,000 | +33340.0% | 2,265,455 | +17194.9% | 0.44% | +43500.0% |
| Q3 2017 | $25,000 | – | 13,099 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,133,583 | $4,104,000 | 3.61% |
| GREAT POINT PARTNERS LLC | 1,537,873 | $5,567,000 | 1.14% |
| BVF INC/IL | 1,392,720 | $5,042,000 | 1.01% |
| Boxer Capital, LLC | 525,000 | $1,901,000 | 0.74% |
| Vivo Capital, LLC | 500,000 | $1,810,000 | 0.60% |
| Healthcare Value Capital, LLC | 150,000 | $543,000 | 0.58% |
| Cormorant Asset Management, LP | 1,000,000 | $3,620,000 | 0.49% |
| Telemetry Investments, L.L.C. | 120,807 | $437,000 | 0.25% |
| Palo Alto Investors LP | 1,162,473 | $4,208,000 | 0.24% |
| NEA Management Company, LLC | 1,298,274 | $4,700,000 | 0.19% |